Self-Care

Balance

Discover Your
Journey to
Optimal Health

Immerse yourself in a journey toward better health with wellness practices, stress management techniques, and insightful tips to enhance your overall well-being and vitality.

Expression

Self-care

Rediscover your inner peace

Holistic well-begin

24k

People empowered through our work

18

Successful Self Care & Rediscover body

Our Mission

At IG ♡ Health, we believe everyone should have the opportunity to access the private market, so we’ve developed technology to make it accessible, liquid, and transparent for all.

Our mission is to provide a wider range of people with the ability to buy and sell shares in the world's most innovative healthcare companies and to help everyone who participates in the private market economy.

Our solution makes it easy for clients to invest their money in company stocks and IPOs, and for individual and institutional investors to contribute to and potentially benefit from the growth of private companies.

Benefits

Our advantages

  • Opportunity to invest from $20

  • Capital insurance

  • Large network of private and institutional investors

  • Commission profit

  • Diversification of IPO portfolio

Health Tech IPOs

Participate in the healthcare revolution by investing in advanced medical technology IPOs!

IG Health's core investment areas are companies developing vaccines, prosthetics and life-saving medicines, each of which is showing strong growth and attracting the attention of investors around the world. These sectors not only respond to critical healthcare needs, but also generate sustainable growth and profitability through sustained demand and high social value.

Medical Solutions

Unlocking Potential in
High-Growth Healthcare Segments

  • 01 Vaccines

  • 02 Prosthetics

  • 03 Essential Medicines

  • 04 Growth Stability

bg

Vaccines

Vaccines are one of the fastest growing segments of the pharmaceutical market. According to recent studies, the global vaccine market is valued at $65 billion and is projected to reach $215 billion by 2030 at an average annual growth rate of over 27.4%.

The vaccines segment, in particular, showed significant growth during the global pandemic, when global vaccination demand reached record levels with more than 15 billion doses of vaccines produced. During the 2021 pandemic, leaders in vaccine development such as Moderna, Johnson & Johnson, Pfizer, and BioNTech grew their revenues 10-50 times year-on-year, highlighting the return potential and importance of investing in this sector.

Health Tech IPOs

IG Launch history

  • (IZTC)

    Invizyne Technologies, Inc.

    About company

    Invizyne Technologies, Inc. operates as a synthetic biochemical company. Its SimplePath platform produces a range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds, as well as consists of a series of modular cascading enzyme based biomanufacturing systems that natural processes to perform chemical conversions.

    • Status: In progress

    • Investment period: November 2024 -

    bg

  • (XCH)

    XCHG Limited

    About company

    XCHG Limited, together with its subsidiaries, engages in designing, manufacturing, and selling of electric vehicle (EV) chargers under the X-Charge brand name in Europe, the People’s Republic of China, the United States, and internationally.

    The company offers direct current (DC) fast chargers under the C6 series and C7 series; and battery-integrated DC fast chargers under the Net Zero series, as well as software system upgrades and hardware maintenance services.

    • Status: Completed

    • Investment period: September 2024 - October 2024

    • Total return: 205,46%

    bg

  • (PGHL)

    Primega Group Holdings Ltd

    About company

    Primega Group Holdings Ltd. engages in the provision of transportation services through its subsidiary, Primega Construction. Its services include soil and rock transportation, diesel oil trading, and construction works such as excavation and lateral support works and bored piling. The company was founded on April 14, 2022 and is headquartered in Hong Kong.

    • Status: Completed

    • Investment period: July 2024 - September 2024

    • Total return: 116,81%

    bg

  • (ACTU)

    Actuate Therapeutics Inc

    About company

    Actuate’s lead drug, elraglusib (a novel GSK-3 inhibitor), targets multiple molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy. Elraglusib is also emerging as a mediator of anti-tumor immunity through the inhibition of multiple immune checkpoints and the regulation of immune cell function.

    • Status: Completed

    • Investment period: August 2024 - September 2024

    • Total return: -6,65%

    bg

Co-operation with IG Health

By partnering with IG Health, we provide each investor with a comprehensive and carefully considered approach to selecting IPO projects for capital investment. Our team of experts analyses companies based on their long-term strategies and cutting-edge technologies, selecting projects with high growth and sustainability potential. This structured and strategic approach effectively minimises risk and maximises returns for our investors.

Описание изображения